De Fino, Chiara
 Distribuzione geografica
Continente #
NA - Nord America 928
EU - Europa 829
AS - Asia 156
AF - Africa 12
SA - Sud America 5
Continente sconosciuto - Info sul continente non disponibili 3
OC - Oceania 3
Totale 1.936
Nazione #
US - Stati Uniti d'America 928
DE - Germania 326
SE - Svezia 219
CN - Cina 103
IT - Italia 60
IE - Irlanda 50
FR - Francia 48
UA - Ucraina 47
GB - Regno Unito 36
IN - India 21
FI - Finlandia 16
CI - Costa d'Avorio 9
VN - Vietnam 9
BE - Belgio 6
JP - Giappone 5
TR - Turchia 5
CL - Cile 4
IL - Israele 4
SG - Singapore 4
A2 - ???statistics.table.value.countryCode.A2??? 3
IR - Iran 3
RU - Federazione Russa 3
AT - Austria 2
AU - Australia 2
CZ - Repubblica Ceca 2
MD - Moldavia 2
NL - Olanda 2
SK - Slovacchia (Repubblica Slovacca) 2
BG - Bulgaria 1
BR - Brasile 1
CH - Svizzera 1
EG - Egitto 1
HU - Ungheria 1
KE - Kenya 1
KZ - Kazakistan 1
LI - Liechtenstein 1
MK - Macedonia 1
NP - Nepal 1
NZ - Nuova Zelanda 1
PL - Polonia 1
PT - Portogallo 1
RO - Romania 1
TN - Tunisia 1
Totale 1.936
Città #
Chandler 313
Ashburn 61
Dublin 50
San Mateo 38
Wilmington 37
Jacksonville 35
Nürnberg 31
Beijing 29
New York 26
Nanjing 23
Boston 22
Princeton 19
Ann Arbor 18
Milan 16
Cattolica 14
Nanchang 14
Dearborn 13
Norwalk 13
Lawrence 12
Marseille 10
Abidjan 9
Hanoi 9
Bremen 8
Falls Church 8
Hebei 8
Woodbridge 8
Chicago 7
Houston 7
Brussels 6
Mountain View 6
Pune 6
Shanghai 6
Fairfield 5
Izmir 5
Lviv 5
Rome 5
Andover 4
Coquimbo 4
Fremont 4
Helsinki 4
Leawood 4
Redwood City 4
Seattle 4
Augusta 3
Changchun 3
Edinburgh 3
Fairport 3
Florence 3
Fuzhou 3
Jiaxing 3
Kunming 3
Lancaster 3
Los Angeles 3
Munich 3
Amsterdam 2
Atlanta 2
Boardman 2
Buffalo 2
Changsha 2
Chengdu 2
Chiavari 2
Chisinau 2
Chiswick 2
Clearwater 2
Frankfurt am Main 2
Gunzenhausen 2
Saint Louis 2
Shenyang 2
Tappahannock 2
Tehran 2
Almaty 1
Asciano 1
Auckland 1
Bangalore 1
Berlin 1
Brno 1
Budapest 1
Busto Arsizio 1
Cagliari 1
Cairo 1
Cormeilles-en-Parisis 1
Costa Mesa 1
Dallas 1
Duncan 1
Easton 1
Eden Prairie 1
Fukuoka 1
Guangzhou 1
Haifa 1
Hangzhou 1
Hounslow 1
Jerusalem 1
Kathmandu 1
Kemerovo 1
Kherson 1
Kilburn 1
Lisbon 1
London 1
Messina 1
Montague 1
Totale 1.025
Nome #
Second-Line Therapy with Fingolimod for Relapsing-Remitting Multiple Sclerosis in Clinical Practice: The Effect of Previous Exposure to Natalizumab 191
Second-Line Therapy with Fingolimod for Relapsing-Remitting Multiple Sclerosis in Clinical Practice: The Effect of Previous Exposure to Natalizumab 144
Sleep Disordered Breathing in a cohort of patients with sporadic Inclusion Body Myositis. 110
Idiopathic inflammatory myopathies evaluated by near infrared spectroscopy 95
Intravascular large B-cell lymphoma presenting as slowly progressive paraparesis with normal MRI features 92
Alemtuzumab-induced lung injury in multiple sclerosis: Learning from adversity in three patients 70
Depression in multiple sclerosis: effect of brain derived neurotrophic factor Val66Met polymorphism and disease perception 68
An atypical case of acute disseminated encephalomyelitis associated with cytomegalovirus infection 67
Disease Reactivation after Fingolimod Discontinuation in Pregnant Multiple Sclerosis Patients 63
Alemtuzumab-induced lung injury in multiple sclerosis: Learning from adversity in three patients 60
Magnetic resonance imaging pattern recognition in sporadic Inclusion-Body Myositis 58
Expression Profile of Long Non-Coding RNAs in Serum of Patients with Multiple Sclerosis. 57
Defining the disease course of TNFα blockers-associated Multiple Sclerosis 56
Focal muscle vibration, an effective rehabilitative approach in severe gait impairment due to multiple sclerosis 53
A pilot study of lncRNAs expression profile in serum of progressive multiple sclerosis patients 53
BDNF rs6265 polymorphism methylation in Multiple Sclerosis: A possible marker of disease progression 52
Correction: BDNF rs6265 polymorphism methylation in Multiple Sclerosis: A possible marker of disease progression(PLoS ONE (2018) 1310 (e0206140) DOI: 10.1371/journal.pone.0206140) 51
Severe dyspnoea with alteration of the diffusion capacity of the lung associated with fingolimod treatment 49
The predictive value of CSF multiple assay in multiple sclerosis: A single center experience 49
A unique case of multiphasic ADEM or what else? 48
The Prevalence of Multiple Sclerosis in the Metropolitan Area of Rome: A Capture-Recapture Analysis 46
Exit strategies for “needle fatigue” in multiple sclerosis: a propensity score-matched comparison study 46
Sativex® effects on promoter methylation and on CNR1/CNR2 expression in peripheral blood mononuclear cells of progressive multiple sclerosis patients 45
Safety and Efficacy of Dimethyl Fumarate in Multiple Sclerosis: An Italian, Multicenter, Real-World Study 45
Identifying Relapses in Multiple Sclerosis Patients through Administrative Data: A Validation Study in the Lazio Region, Italy 43
Liver injury after pulsed methylprednisolone therapy in multiple sclerosis patients 42
Anti-cN1A Antibodies Are Associated with More Severe Dysphagia in Sporadic Inclusion Body Myositis 42
A pilot study of lncRNAs expression profile in serum of progressive multiple sclerosis patients 41
The Expanding Role of the Infectious Disease Expert in the Context of the MS Centre 40
Is serological response to SARS-CoV-2 preserved in MS patients on ocrelizumab treatment? A case report 35
Transient hair loss during treatment with dimethyl-fumarate for multiple sclerosis 23
Delayed hypersensitivity to dimethyl fumarate: Report of 1 case and literature review 18
Neurosarcoidosis presenting as longitudinally extensive myelitis: Diagnostic assessment, differential diagnosis, and therapeutic approach 17
CSF CXCL13 and Chitinase 3-like-1 Levels Predict Disease Course in Relapsing Multiple Sclerosis 15
The predictive value of CSF multiple assay in multiple sclerosis: A single center experience 10
Totale 1.994
Categoria #
all - tutte 8.063
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 8.063


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/201935 0 0 0 0 0 0 0 0 0 0 23 12
2019/2020261 46 30 10 13 11 24 18 13 17 22 42 15
2020/2021117 10 11 1 9 8 7 8 4 13 8 31 7
2021/2022321 30 6 4 42 12 13 0 50 18 20 46 80
2022/2023730 97 111 65 121 41 87 29 58 70 10 27 14
2023/2024195 18 74 7 7 10 33 20 9 7 10 0 0
Totale 1.994